A detailed history of Smith, Salley & Associates transactions in Heart Beam, Inc. stock. As of the latest transaction made, Smith, Salley & Associates holds 250,000 shares of BEAT stock, worth $697,500. This represents 0.04% of its overall portfolio holdings.

Number of Shares
250,000
Previous 250,000 -0.0%
Holding current value
$697,500
Previous $642,000 9.66%
% of portfolio
0.04%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$1.39 - $2.41 $69,500 - $120,500
50,000 Added 25.0%
250,000 $545,000
Q2 2023

Aug 04, 2023

BUY
$1.83 - $2.95 $366,000 - $590,000
200,000 New
200,000 $482,000

Others Institutions Holding BEAT

About HeartBeam, Inc.


  • Ticker BEAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 8,000,870
  • Market Cap $22.3M
  • Description
  • HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a ...
More about BEAT
Track This Portfolio

Track Smith, Salley & Associates Portfolio

Follow Smith, Salley & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.